H1N1 Vaccines Market Research Report by Route of Administration (Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines) - Global Forecast to 2025 - Cumulative Impact of COVID-19

H1N1 Vaccines Market Research Report by Route of Administration (Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines) - Global Forecast to 2025 - Cumulative Impact of COVID-19

The Global H1N1 Vaccines Market is expected to grow from USD 4,020.51 Million/EUR 3,525.26 Million in 2020 to USD 17,688.12 Million/EUR 15,509.28 by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 34.48%.

Market Segmentation & Coverage:

This research report categorizes the H1N1 Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Route of Administration, the H1N1 Vaccines Market studied across Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines.

Based on Geography, the H1N1 Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global H1N1 Vaccines Market including Abbott, Baxter International, Cipla, GSK, Hualan Biological Engineering, Merck, Mitsubishi Tanabe Pharma, Pfizer, Sanofi, and Sinovac Biotech.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the H1N1 Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global H1N1 Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global H1N1 Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global H1N1 Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global H1N1 Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global H1N1 Vaccines Market?
6. What are the modes and strategic moves considered suitable for entering the Global H1N1 Vaccines Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Route of Administration Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
4.3. Geographic Growth Opportunities
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Global H1N1 Vaccines Market, By Route of Administration
6.1. Introduction
6.2. Intradermal Vaccines
6.3. Intramuscular Vaccines
6.4. Intranasal Vaccines
7. Americas H1N1 Vaccines Market
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. Asia-Pacific H1N1 Vaccines Market
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. Europe, Middle East & Africa H1N1 Vaccines Market
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion
11. Company Usability Profiles
11.1. Abbott
11.2. Baxter International
11.3. Cipla
11.4. GSK
11.5. Hualan Biological Engineering
11.6. Merck
11.7. Mitsubishi Tanabe Pharma
11.8. Pfizer
11.9. Sanofi
11.10. Sinovac Biotech
12. Appendix
12.1. Discussion Guide

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook